Washington, DC - Secretary of State John Kerry: Well, good morning, everybody, and a very warm welcome to all the members of our visiting delegation from the African Union, and particularly to the chair, Dr. Dlamini-Zuma – a number of familiar faces that I see here from our visit last April to Addis Ababa, and we’re delighted to welcome you back. And I look forward to a very productive exchange between our teams on the key topics that have been selected. I think it’s going to be very productive. And then, Madam Chair, you and I will have a chance to be able to have a bilat to summarize at the back end of this, and we appreciate that.

Los Angeles, California - Wealthier women who live in communities with the greatest income divide between rich and poor had better access to a new genetic test that can determine the most effective form of treatment for early-stage breast cancer, according to a new study (link is password-protected) by the UCLA Center for Health Policy Research, Harvard Medical School’s Brigham and Women’s Hospital and Aetna. The study, published in the April issue of the journal Health Affairs, also indicated that only a small minority of women with breast cancer received the test at all.

Los Angeles, California - A new UCLA study takes another step toward the early understanding of a degenerative brain condition called chronic traumatic encephalopathy, or CTE, which affects athletes in contact sports who are exposed to repetitive brain injuries. Using a new imaging tool, researchers found a strikingly similar pattern of abnormal protein deposits in the brains of retired NFL players who suffered from concussions.

Cambridge, Massachusetts - Cancer cells often break free from their original locations and circulate through the bloodstream, allowing them to form new tumors elsewhere in the body. Detecting these cells could give doctors a new way to predict whether patients’ tumors will metastasize, or monitor how they are responding to treatment, but finding these extremely rare cells has proven challenging because there might be only one to 10 such cells in a 1-milliliter sample of a patient’s blood.

Berkeley, California - Most of today’s anticancer drugs target the DNA or proteins in tumor cells, but a new discovery by University of California, Berkeley, scientists unveils a whole new set of potential targets: the RNA intermediaries between DNA and proteins.

Dallas, Texas - Sudden cardiac arrest during sports activities is relatively low among physically active middle-aged adults, according to research in the American Heart Association journal Circulation.